新型冠状病毒肺炎疫情期间男科疾病的管理方法与思考

Management of androgenic diseases during the epidemic of COVID-19 pneumonia

新型冠状病毒肺炎(COVID-19),已被国家卫生健康委员会列为乙类传染病,按照甲类传染病进行管理,此次疫情同时被WHO定义为国际关注的突发公共卫生事件。疫情期间非必要的门诊就诊无疑增加了很多病患、医患之间感染的风险。如何为男科疾病患者提供科学的医疗指导显得尤为重要,也是男科管理的当务之急。此外,新型冠状病毒肺炎及其目前临床治疗方案是否会对男性生殖系统造成损伤,也值得广大临床科研工作者关注。

The novel coronavirus(COVID-19)pneumonia has been classified as a category B and dealt with as a category A infectious disease by the National Health Commission of China,and also as a public health emergency of international concern by the World Health Organization.During the epidemic,unnecessary visits to hospitals may increase the risk of infection among patients and clinicians.Therefore,it is particularly important to provide some scientific medical guidance for patients with male diseases,which is also a current imperative for andrology management.And it also deserves the attention of clinical researchers whether COVID-19 pneumonia and its clinical treatments currently used may affect the male reproductive system.